Alexander L. Cappello - 15 Nov 2021 Form 4 Insider Report for NAVIDEA BIOPHARMACEUTICALS, INC.

Role: Director
Signature: /s/ Erika L. Eves for Alexander L. Cappello, by power of attorney
Issuer symbol: N/A
Transactions as of: 15 Nov 2021
Net transactions value: +$30
Form type: 4
Filing time: 02 Dec 2021, 15:11:10 UTC
Previous filing: 01 Oct 2021
Next filing: 04 Jan 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NAVB	Common Stock	Award	$30	+30,000	+797%	$0.001000^*	33,762	15 Nov 2021	Direct	F1
transaction	NAVB	Common Stock	Award	$0	+3,965	+12%	$0.000000	37,727	15 Nov 2021	Direct	F2
transaction	NAVB	Common Stock	Award	$0	+1,250	+3.3%	$0.000000	38,977	30 Nov 2021	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Restricted shares granted pursuant to Issuer's 2014 Amended and Restated Stock Incentive Plan which vest as to one-third on each of the first three anniversaries of the date of grant.
F2	Stock issued under the Amended and Restated 2014 Stock Incentive Plan in partial payment of quarterly non-employee director fees.
F3	Stock issued under the Amended and Restated 2014 Stock Incentive Plan in partial payment of monthly non-employee director fees.